2型糖尿病缓解临床试验中体重减轻后功能性β细胞容量正常化的时间进程
在糖尿病缓解临床试验中,39例2型糖尿病患者经饮食减重后实现缓解,随访2年。功能性β细胞容量在减重后逐渐增加,至12个月时与体重匹配的非糖尿病对照组相似,并在2年持续缓解期间保持不变。
要点
- 减重后功能性β细胞容量逐渐增加,12个月时与非糖尿病对照组相似。
- 2年持续缓解期间,功能性β细胞容量维持不变。
- 第一时相胰岛素反应在5个月时增加后保持稳定,但低于非糖尿病对照组。
核心结论
- 减重后评估的功能性β细胞容量逐渐增加,至12个月时与非糖尿病对照组参与者相似,并在2年持续缓解期间保持不变。
研究设计与样本
- 采用阶梯式胰岛素分泌试验结合精氨酸刺激,通过高血糖和精氨酸刺激量化功能性β细胞容量。
- 57例参与者中39例初始实现缓解(HbA1c <6.5% [<48 mmol/mol] 且未用降糖药时空腹血浆葡萄糖 <7 mmol/L),体重减轻16.4 ± 7.7 kg,并接受避免体重反弹的支持性建议随访。
- 2年时20例参与者仍在研究中处于缓解状态。
- 非糖尿病对照组按年龄、性别和减重后体重与干预组匹配,研究一次。
主要发现
- 缓解期间,中位(四分位距)最大胰岛素分泌率从基线581(480-811)pmol/min/m2增至5个月736(542-998)pmol/min/m2、12个月942(565-1,240)pmol/min/m2(较基线P = 0.028)和24个月936(635-1,435)pmol/min/m2(较基线P = 0.023;n = 39例初始缓解者中的20例)。
- 12个月(P = 0.064)和24个月(P = 0.244)时最大胰岛素分泌率与非糖尿病对照组(1,016 [857-1,507] pmol/min/m2)相当。
- 中位第一时相胰岛素反应从基线42(4-67)pmol/min/m2增至5个月107(59-163)pmol/min/m2(P < 0.0001),12个月和24个月分别稳定在110(59-201)和125(65-166)pmol/min/m2(均较基线P < 0.0001),但低于非糖尿病对照组250(226-429)pmol/min/m2(P < 0.0001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess functional β-cell capacity in type 2 diabetes during 2 years of remission induced by dietary weight loss. RESEARCH DESIGN AND METHODS: A Stepped Insulin Secretion Test with Arginine was used to quantify functional β-cell capacity by hyperglycemia and arginine stimulation. Thirty-nine of 57 participants initially achieved remission (HbA1c <6.5% [<48 mmol/mol] and fasting plasma glucose <7 mmol/L on no antidiabetic drug therapy) with a 16.4 ± 7.7 kg weight loss and were followed up with supportive advice on avoidance of weight regain. At 2 years, 20 participants remained in remission in the study. A nondiabetic control (NDC) group, matched for age, sex, and weight after weight loss with the intervention group, was studied once. RESULTS: During remission, median (interquartile range) maximal rate of insulin secretion increased from 581 (480-811) pmol/min/m2 at baseline to 736 (542-998) pmol/min/m2 at 5 months, 942 (565-1,240) pmol/min/m2 at 12 months (P = 0.028 from baseline), and 936 (635-1,435) pmol/min/m2 at 24 months (P = 0.023 from baseline; n = 20 of 39 of those initially in remission). This was comparable to the NDC group (1,016 [857-1,507] pmol/min/m2) by 12 (P = 0.064) and 24 (P = 0.244) months. Median first-phase insulin response increased from baseline to 5 months (42 [4-67] to 107 [59-163] pmol/min/m2; P < 0.0001) and then remained stable at 12 and 24 months (110 [59-201] and 125 [65-166] pmol/min/m2, respectively; P < 0.0001 vs. baseline) but lower than that of the NDC group (250 [226-429] pmol/min/m2; P < 0.0001). CONCLUSIONS: A gradual increase in assessed functional β-cell capacity occurred after weight loss, becoming similar to that of NDC group participants by 12 months. This result was unchanged at 2 years with continuing remission of type 2 diabetes.
引用
- Zhyzhneuskaya SV, Al-Mrabeh A, Peters C, et al. Time Course of Normalization of Functional β-Cell Capacity in the Diabetes Remission Clinical Trial After Weight Loss in Type 2 Diabetes. Diabetes Care. 2020. PMID: 32060017. doi:10.2337/dc19-0371
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。